CD274 and vitiligo: Colitis, rash, and hypophysitis are the most frequent adverse effects of CTLA4 inhibitors, whereas arthralgia, pneumonitis, vitiligo, and hypothyroidism are most frequent with PD-L1 inhibitors (5), with high temporal unpredictability (6).